Telix Pharmaceuticals is trading at A$17.09, -4.26%, with no specific catalyst identified.
- No new company-specific announcement dated September 21, 2026 was identified.
- Telix’s next scheduled catalyst is its September 22 R&D Day.
- Broader market context was broadly stable, with major indices unchanged; available evidence does not establish a specific catalyst for the move.